Fibromyalgia Syndrome and Cognitive Decline: The Role of Body Mass Index and Clinical Symptoms
Metadata
Show full item recordEditorial
MDPI
Date
2022-06-14Referencia bibliográfica
Muñoz Ladrón de Guevara, C... [et al.]. Fibromyalgia Syndrome and Cognitive Decline: The Role of Body Mass Index and Clinical Symptoms. J. Clin. Med. 2022, 11, 3404. [https://doi.org/10.3390/jcm11123404]
Sponsorship
Spanish Government RTI2018-095830-B-I00/AEI/10.13039/501100011033Abstract
The high prevalence of obesity and overweight in fibromyalgia (FM) may be an important
factor in the well-known cognitive deficits seen in the disorder. This study analyzed the influence
of body mass index (BMI) and primary clinical symptoms of FM (pain, fatigue, insomnia, anxiety,
and depression) on attention, memory, and processing speed in FM. Fifty-two FM patients and
thirty-two healthy participants completed cognitive tasks assessing selective, sustained, and divided
attention; visuospatial and verbal memory; and information processing speed. Furthermore, they
were evaluated in terms of the main clinical symptoms of the disorder. FM patients showed a
marked reduction of cognitive performance in terms of selective, sustained, and divided attention;
visuospatial memory; and processing speed, but no group differences were observed in verbal
memory. BMI negatively affects sustained and selective attention, verbal memory, and processing
speed and is the main predictor of performance in these basic cognitive domains. Our findings
confirm the presence of cognitive deficits with respect to attention and visual memory, as well as
slower processing speed, in FM. Moreover, the results support a role of BMI in the observed cognitive
deficits. Interventions increasing physical activity and promoting cognitive stimulation could be
useful for strengthening cognitive function in FM patients.